Effect of Dacarbazine Chemotherapy in Well-Differentiated Neuroendocrine Tumors

被引：0
作者：
Mueller, D. [1 ]
Rinke, A. [1 ]
Gress, T. [1 ]
机构：
[1] Univ Marburg, Dept Internal Med, Div Gastroenterol & Endocrinol, D-3550 Marburg, Germany
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
neuroendocrine tumor; chemotherapy; dacarbazine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease
    Hendifar, Andrew E.
    Marchevsky, Alberto M.
    Tuli, Richard
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 425 - 436
  • [32] Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
    Sebastian Krug
    Thomas Kegel
    Thomas M. Gress
    Anja Rinke
    Leonidas Apostolidis
    Henning Jann
    Alexander König
    Dieter Hörsch
    Jörg Schrader
    Thomas J. Ettrich
    Michael Richter
    Jörg Steighardt
    Patrick Michl
    [J]. BMC Cancer, 21
  • [33] Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
    Krug, Sebastian
    Kegel, Thomas
    Gress, Thomas M.
    Rinke, Anja
    Apostolidis, Leonidas
    Jann, Henning
    Koenig, Alexander
    Hoersch, Dieter
    Schrader, Joerg
    Ettrich, Thomas J.
    Richter, Michael
    Steighardt, Joerg
    Michl, Patrick
    [J]. BMC CANCER, 2021, 21 (01)
  • [34] Well-differentiated neuroendocrine tumor and osteoporosis: incidental findings?
    Poiana, Catalina
    Carsote, Mara
    Neamtu, M. C.
    Avramescu, Elena Taina
    Vasilescu, Florina
    Terzea, Dana
    Paun, Diana
    Trifanescu, Raluca
    Miulescu, Rucsandra Danciulescu
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2013, 54 (04) : 1169 - 1171
  • [35] Well-Differentiated Neuroendocrine Carcinoma of the Extrahepatic Biliary Duct
    Koksal, Hande
    Ugras, N. Serdar
    Uysal, Bulent
    Boruban, M. Cem
    [J]. EUROPEAN JOURNAL OF GENERAL MEDICINE, 2015, 12 (02): : 157 - 159
  • [36] CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience
    Sahu, Arvind
    Jefford, Michael
    Lai-Kwon, Julia
    Thai, Alesha
    Hicks, Rodney J.
    Michael, Michael
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [37] Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
    Brighi, Nicole
    Lamberti, Giuseppe
    Andrini, Elisa
    Mosconi, Cristina
    Manuzzi, Lisa
    Donati, Giada
    Lisotti, Andrea
    Campana, Davide
    [J]. CURRENT ONCOLOGY, 2023, 30 (02) : 1381 - 1394
  • [38] Gallbladder primary well-differentiated neuroendocrine tumor: A misdiagnosed case
    Dammak, Nouha
    Ammar, Houssem
    Ben Latifa, Mahdi
    Belkacem, Oussama
    Ben Mabrouk, Mohamed
    Ben Ali, Ali
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2023, 111
  • [39] Gemcitabine and Oxaliplatin Combination Chemotherapy for Metastatic Well-differentiated Neuroendocrine Carcinomas A Single-Center Experience
    Cassier, Philippe A.
    Walter, Thomas
    Eymard, Beatrice
    Ardisson, Philippe
    Perol, Maurice
    Paillet, Carole
    Chayvialle, Jean-Alain
    Scoazec, Jean-Yves
    Hervieu, Valerie
    Bohas, Catherine Lombard
    [J]. CANCER, 2009, 115 (15) : 3392 - 3399
  • [40] Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
    Ito, Tetsuhide
    Honma, Yoshitaka
    Hijioka, Susumu
    Kudo, Atsushi
    Fukutomi, Akira
    Nozaki, Akira
    Kimura, Yasutoshi
    Motoi, Fuyuhiko
    Isayama, Hiroyuki
    Komoto, Izumi
    Hisamatsu, Seiichi
    Nakajima, Akihiro
    Shimatsu, Akira
    [J]. INVESTIGATIONAL NEW DRUGS, 2017, 35 (04) : 499 - 508
12345